Taysha Gene Therapies, Inc. (TSHA): 10-Q filed May 6, 2026

Form type

10-Q

Filing date

May 6, 2026

Accession number

0001193125-26-207666

Filer

Taysha Gene Therapies, Inc. (CIK 1806310)